Related Articles
Dihydroartemisinin triggers c‑Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T‑cell lymphoma cells
Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-Jun leading to cell apoptosis
Notch1 targeted regulation of mir-224/LRIG2 signaling for the proliferation and apoptosis of cervical cancer cells
Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway